The Effects of Kinesiophobia and Proprioception on Disability and Function in Rheumatoid Hand

NCT ID: NCT07141927

Last Updated: 2025-08-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-18

Study Completion Date

2024-07-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a cross-sectional study aimed at examining the effects of kinesiophobia and proprioception on disability and function in the rheumatoid hand, compared to healthy controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rheumatoid arthritis (RA) is a fairly common chronic inflammatory disease. Up to 90% of wrist and finger joints are affected by RA. Thus, it is known that a decrease in performance-based function and disability occur in the hand. Kinesiophobia leads to avoidance behavior, especially in painful conditions. Kinesiophobia has been shown to be a significant mental factor leading to functional loss and disability in rheumatoid hand (RH). On the other hand, joint repositioning sense measurements, which show proprioceptive losses in the wrist and hand joints due to the effects of RA, have been demonstrated. However, as far as we know, the contributions of these mental and biological factors (kinesiophobia + proprioception) to the function and disability of RH have not been examined together.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis (RA)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RA group

RA volunteers followed in the rheumatology outpatient clinic of a university hospital

Measurements

Intervention Type OTHER

First, the demographic characteristics of all participants were recorded. For those who met the inclusion criteria, primary and secondary outcome measurements were performed by the same physical therapist in a single session

Healthy controls

Hospital staff and volunteer companions of these RA patients

Measurements

Intervention Type OTHER

First, the demographic characteristics of all participants were recorded. For those who met the inclusion criteria, primary and secondary outcome measurements were performed by the same physical therapist in a single session

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Measurements

First, the demographic characteristics of all participants were recorded. For those who met the inclusion criteria, primary and secondary outcome measurements were performed by the same physical therapist in a single session

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of RA
* Volunteering
* Being between the ages of 18 and 65


* Being healthy.
* Being between 18-65 years old.
* Being a volunteer

Exclusion Criteria

* The presence of another rheumatic disease or chronic illness that could affect function and cause disability.
* Pain, deformity, or other cooperation issues (such as severe mental, visual, or hearing impairments) that prevent participation in measurements.
* Sensory loss in the upper extremity, history of surgery, and injury in the last six months.


* Any diagnosis of chronic or acute illness.
* In the upper extremity, history of surgery injury in the last six months.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cumhuriyet University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Selvin BALKİ

associate professor, Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sivas Cumhuriyet University

Sivas, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SCU-FTR-SB-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.